
Young Kim
U.S. Representative for California's 40th District
Republican · Since 2021 · Next election: 2026 · Age 63
Last updated · 7 sources
Young Kim is the U.S. Representative for California's 40th District, a Republican serving since 2021.
Kim has served in the House longer than 161 of its 438 other members and longer than 16 of California's 51 other House members.
Kim sits on 3 committees: Financial Services, Foreign Affairs, and Strategic Competition Between the United States and the Chinese Communist Party.
In the House's last 30 days in session (May 19 – Oct 2, 2026), Kim voted in 139 of 139 roll calls (100%). In that period, 84 bills Kim sponsored or cosponsored had new actions.
Kim has filed with the FEC to run for this seat in 2026. 12 candidates for the seat have reported receipts to the FEC.
This week (Sep 28 – Oct 4, 2026)
Full schedule →House: pro forma sessions Mon and Thu
Votes
All of them →Voted in 139 of 139 roll calls (100%), May 19 – Oct 2, 2026.
Kim voted with the majority of House Republicans on 137 roll calls and against it on 2.
Votes against the party majority
Legislation
55 bills sponsored and 378 cosponsored in the 119th Congress
H.R. 10675 To strengthen critical mineral, energy, manufacturing and technology supply chains, advance innovation and allied cooperation, enhance United States technological leadership and competitiveness, and for other purposes.
Cosponsor · Latest action Oct 1, 2026: Referred to the House Committee on Foreign Affairs.
H.R. 7008 Stop Insider Trading Act
Cosponsor · Latest action Sep 30, 2026: Cloture on the motion to proceed to the measure not invoked in Senate by Yea-Nay Vote. 53 - 47. Record Vote Number: 253.
This bill generally prohibits Members of Congress and their spouses and dependent children from purchasing stocks and requires public notice before these individuals may sell stocks.
H.R. 8205 Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Cosponsor · Latest action Sep 28, 2026: Passed Senate without amendment by Voice Vote. (consideration: CR S5120)
This bill reauthorizes through FY2031 and revises programs that support research and development of drugs and other therapies to address amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease) and other neurodegenerative diseases.
Campaign finance
- Raised
- $8,837,239
- Spent
- $8,893,142
- Cash on hand
- $1,680,490
2026 election cycle, through Jun 30, 2026 · FEC H8CA39240
California senators
Adam SchiffU.S. Senator for California · Democrat
Alex PadillaU.S. Senator for California · Democrat
Sources
- congress-legislators (member data, CC0) · retrieved Oct 2, 2026
- Portrait: Public domain (U.S. government work)
- House roll-call votes (Office of the Clerk)
- Bill status (Congress.gov / GovInfo BILLSTATUS) · retrieved Oct 2, 2026
- Campaign finance (Federal Election Commission) · retrieved Oct 2, 2026
- District profile (Census Bureau, 2020–2024 American Community Survey 5-year estimates)